Polygenic basis and biomedical consequences of telomere length variation
- PMID: 34611362
- PMCID: PMC8492471
- DOI: 10.1038/s41588-021-00944-6
Polygenic basis and biomedical consequences of telomere length variation
Abstract
Telomeres, the end fragments of chromosomes, play key roles in cellular proliferation and senescence. Here we characterize the genetic architecture of naturally occurring variation in leukocyte telomere length (LTL) and identify causal links between LTL and biomedical phenotypes in 472,174 well-characterized UK Biobank participants. We identified 197 independent sentinel variants associated with LTL at 138 genomic loci (108 new). Genetically determined differences in LTL were associated with multiple biological traits, ranging from height to bone marrow function, as well as several diseases spanning neoplastic, vascular and inflammatory pathologies. Finally, we estimated that, at the age of 40 years, people with an LTL >1 s.d. shorter than the population mean had a 2.5-year-lower life expectancy compared with the group with ≥1 s.d. longer LDL. Overall, we furnish new insights into the genetic regulation of LTL, reveal wide-ranging influences of LTL on physiological traits, diseases and longevity, and provide a powerful resource available to the global research community.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Genetic susceptibility to chronic diseases leads to heart failure among Europeans: the influence of leukocyte telomere length.Hum Mol Genet. 2024 Jul 6;33(14):1262-1272. doi: 10.1093/hmg/ddae063. Hum Mol Genet. 2024. PMID: 38676403
-
Modifiable traits, healthy behaviours, and leukocyte telomere length: a population-based study in UK Biobank.Lancet Healthy Longev. 2022 May;3(5):e321-e331. doi: 10.1016/S2666-7568(22)00072-1. Lancet Healthy Longev. 2022. PMID: 35685390 Free PMC article.
-
Breaking down causes, consequences, and mediating effects of telomere length variation on human health.Genome Biol. 2024 May 17;25(1):125. doi: 10.1186/s13059-024-03269-9. Genome Biol. 2024. PMID: 38760657 Free PMC article.
-
A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study.Front Immunol. 2022 Jul 15;13:922922. doi: 10.3389/fimmu.2022.922922. eCollection 2022. Front Immunol. 2022. PMID: 35911771 Free PMC article.
-
Telomere length in cardiovascular disease: new challenges in measuring this marker of cardiovascular aging.Future Cardiol. 2011 Nov;7(6):789-803. doi: 10.2217/fca.11.55. Future Cardiol. 2011. PMID: 22050065 Review.
Cited by
-
Whole exome sequencing analyses reveal novel genes in telomere length and their biomedical implications.Geroscience. 2024 Jun 5. doi: 10.1007/s11357-024-01203-2. Online ahead of print. Geroscience. 2024. PMID: 38837026
-
Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis.Neurol Genet. 2024 May 29;10(3):e200159. doi: 10.1212/NXG.0000000000200159. eCollection 2024 Jun. Neurol Genet. 2024. PMID: 38817245 Free PMC article.
-
Exploring the Causal Effects of Mineral Metabolism Disorders on Telomere and Mitochondrial DNA: A Bidirectional Two-Sample Mendelian Randomization Analysis.Nutrients. 2024 May 8;16(10):1417. doi: 10.3390/nu16101417. Nutrients. 2024. PMID: 38794655 Free PMC article.
-
Validation of human telomere length multi-ancestry meta-analysis association signals identifies POP5 and KBTBD6 as human telomere length regulation genes.Nat Commun. 2024 May 24;15(1):4417. doi: 10.1038/s41467-024-48394-y. Nat Commun. 2024. PMID: 38789417 Free PMC article.
-
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.medRxiv [Preprint]. 2024 May 10:2024.05.10.24307164. doi: 10.1101/2024.05.10.24307164. medRxiv. 2024. PMID: 38766261 Free PMC article. Preprint.
References
Publication types
MeSH terms
Grants and funding
- MR/L003120/1/MRC_/Medical Research Council/United Kingdom
- MC_PC_17228/MRC_/Medical Research Council/United Kingdom
- RG/13/13/30194/BHF_/British Heart Foundation/United Kingdom
- MR/M012816/1/MRC_/Medical Research Council/United Kingdom
- CH/12/2/29428/BHF_/British Heart Foundation/United Kingdom
- R/L003120/1/MRC_/Medical Research Council/United Kingdom
- RG/18/13/33946/BHF_/British Heart Foundation/United Kingdom
- SP/16/4/32697/BHF_/British Heart Foundation/United Kingdom
- BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- K08 HG010155/HG/NHGRI NIH HHS/United States
- MC_QA137853/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources